These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 11944643)

  • 1. PMA primacy: synthesizing the 35 U.S.C. Section 156 patent term extension, 35 U.S.C. Section 271(e)(1) patent infringement exemption as currently applied to medical devices, and medical device preemption jurisprudence to yield a cohesive solution regarding scope of coverage.
    Flaherty JM
    Food Drug Law J; 2001; 56(3):339-49. PubMed ID: 11944643
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of Food and Drug Administration 510(k) notifications in patent litigation.
    Tolomeo DE
    Food Drug Law J; 2004; 59(4):465-77. PubMed ID: 15875346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Express preemption and premarket approval under the Medical Device Amendments.
    Scandaglia GJ; Tully TL
    Food Drug Law J; 2004; 59(2):245-64. PubMed ID: 15318395
    [No Abstract]   [Full Text] [Related]  

  • 4. To have (medical devices) or not: what's safer for patients?
    McCormack J
    Health Facil Manage; 1995 Jun; 8(6):44, 46, 48. PubMed ID: 10142630
    [No Abstract]   [Full Text] [Related]  

  • 5. A pivotal medical-device case.
    Sonder G
    N Engl J Med; 2008 Apr; 358(16):1758. PubMed ID: 18426012
    [No Abstract]   [Full Text] [Related]  

  • 6. If it's regulated like a duck ... uncertainties in implementing the patent exceptions of the Drug Price Competition and Patent Term Restoration Act.
    Bloch DJ
    Food Drug Law J; 1999; 54(1):111-26. PubMed ID: 11758554
    [No Abstract]   [Full Text] [Related]  

  • 7. A pivotal medical-device case.
    Greenspan H
    N Engl J Med; 2008 Apr; 358(16):1758. PubMed ID: 18420514
    [No Abstract]   [Full Text] [Related]  

  • 8. Forces reshaping the performance and contribution of the U.S. medical device industry.
    Benson JS
    Food Drug Law J; 1996; 51(2):331-6. PubMed ID: 11822326
    [No Abstract]   [Full Text] [Related]  

  • 9. Guide to preemption of state-law claims against Class III PMA medical devices.
    Whitney DW
    Food Drug Law J; 2010; 65(1):113-39, ii-iii. PubMed ID: 24475536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the patent and trademark office under 35 U.S.C. section 156.
    Tyson KL
    Food Drug Law J; 1999; 54(2):205-9. PubMed ID: 11758574
    [No Abstract]   [Full Text] [Related]  

  • 11. Implications of international drug approval systems on confidentiality of business secrets in the U.S. pharmaceutical industry.
    O'Reilly JT
    Food Drug Law J; 1998; 53(1):123-32. PubMed ID: 11795328
    [No Abstract]   [Full Text] [Related]  

  • 12. A pivotal medical-device case.
    Curfman GD; Morrissey S; Drazen JM
    N Engl J Med; 2008 Jan; 358(1):76-7. PubMed ID: 18172178
    [No Abstract]   [Full Text] [Related]  

  • 13. Patent infringement. Generic HIV drugmaker's patent claim is time-barred.
    AIDS Policy Law; 2003 Aug; 18(16):6. PubMed ID: 14626916
    [No Abstract]   [Full Text] [Related]  

  • 14. Watchdog group says "massive lobbying effort" by medical device industry threatens public health.
    Lenzer J
    BMJ; 2012 Feb; 344():e1521. PubMed ID: 22374926
    [No Abstract]   [Full Text] [Related]  

  • 15. Medical device preemption after Medtronic, Inc. v. Lohr.
    Neraas MB
    Food Drug Law J; 1996; 51(4):619-29. PubMed ID: 11797731
    [No Abstract]   [Full Text] [Related]  

  • 16. Medical devices; establishment registration and device listing for manufacturers and distributors of devices; correction--FDA. Proposed rule; correction.
    Fed Regist; 1998 Nov; 63(228):65566. PubMed ID: 10338876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clarification: 510k is premarket notification; it provides no patent or FDA approval.
    Burkhart CG
    J Drugs Dermatol; 2008 Feb; 7(2):105. PubMed ID: 18335644
    [No Abstract]   [Full Text] [Related]  

  • 18. Medical device reporting: issues with Class III medical devices.
    Zigler J; Walsh J; Zigler J
    Food Drug Law J; 2007; 62(3):573-80. PubMed ID: 17915398
    [No Abstract]   [Full Text] [Related]  

  • 19. Premarket approval and federal preemption of product liability claims in the wake of Medtronic, Inc. v. Lohr.
    Jarcho DG
    Food Drug Law J; 1996; 51(4):613-8. PubMed ID: 11797730
    [No Abstract]   [Full Text] [Related]  

  • 20. Judicial review of FDA preemption determinations.
    Frost A
    Food Drug Law J; 1999; 54(3):367-88. PubMed ID: 11797704
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.